Standard BioTools Inc. (LAB) Q1 2025 Earnings Conference Call Transcript
Standard BioTools Inc. (NASDAQ:LAB ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants John Graziano - VP of IR Michael Egholm - President & CEO Alex Kim - CFO Conference Call Participants Kyle Boucher - TD Cowen Matt Stanton - Jefferies Paul Knight - KeyBanc Operator Good day and welcome to the Standard BioTools, Inc., First Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates
Standard BioTools (LAB) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.23 per share a year ago.
Standard BioTools Inc. (LAB) Q4 2024 Earnings Call Transcript
Standard BioTools Inc. (NASDAQ:LAB ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Michael Egholm - President & CEO Alex Kim - Chief Operating Officer & Interim-CFO Conference Call Participants Matt Stanton - Jefferies Kyle Boucher - TD Cowen Paul Knight - KeyBanc Operator Good day, everyone, and welcome to Standard BioTools' Fourth Quarter and Full Year 2024 Financial Results Conference Call. As a reminder, this conference is being recorded.
Standard BioTools Inc. (LAB) Q3 2024 Earnings Call Transcript
Standard BioTools Inc. (NASDAQ:LAB ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants David Holmes - IR Michael Egholm - President & CEO Alex Kim - Chief Operating Officer & Interim-CFO Conference Call Participants Matt Stanton - Jefferies Operator Good day and welcome to the Standard BioTools Inc Third Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode.
Standard BioTools (LAB) Reports Q3 Loss, Tops Revenue Estimates
Standard BioTools (LAB) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.15 per share a year ago.
Standard BioTools And 2 Other Penny Stocks Executives Are Buying
The Dow Jones index closed higher by around 10 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.
Standard BioTools And 3 Other Stocks Under $3 Executives Are Buying
The Dow Jones index closed higher by around 0.2% on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.
Standard BioTools Inc. (LAB) Q2 2024 Earnings Call Transcript
Standard BioTools Inc. (NASDAQ:LAB ) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET Company Participants David Holmes - IR Michael Egholm - President and CEO Jeff Black - CFO Conference Call Participants Matt Stanton - Jefferies Dan Brennan - TD Cowen Paul Knight - KeyBanc Operator Good day and welcome to the Standard BioTools Second Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode.
Standard BioTools (LAB) Reports Q2 Loss, Misses Revenue Estimates
Standard BioTools (LAB) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.14 per share a year ago.
